| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |